{"cluster": 57, "subcluster": 12, "abstract_summ": " Novel coronavirus SARS-CoV-2 is known to be susceptible in vitro to exposure to hydroxychloroquine and its effect has been found to be potentiated by azithromycin . We hypothesise that early administration of hydroxy chloroquine can prevent respiratory deterioration in patients admitted to intensive care due to rapidly progressive COVID-19 infection . At present, there is no data from RCTs on their safety and efficacy ."}